Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
CANC
53
HOLDINGS
15%
ALSO IN XPH
XPH
47
HOLDINGS
17%
ALSO IN CANC
SECTOR DRIFT (CANC minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 5.0% | 3.0% | 3.0% |
|
MERCK & CO. INC. | 2.6% | 2.7% | 2.6% |
|
JOHNSON & JOHNSON | 3.0% | 2.6% | 2.6% |
|
BRISTOL-MYERS SQUIBB CO | 3.3% | 2.5% | 2.5% |
|
NUVATION BIO INC CLASS A | 2.0% | 3.6% | 2.0% |
CANC Overweight Relative to XPH
|
REVOLUTION MEDICINES, INC. | 6.3% |
 |
ASTRAZENECA PLC | 4.3% |
|
BRIDGEBIO PHARMA, INC. | 4.2% |
 |
NOVARTIS AG | 4.1% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 3.8% |
 |
GENMAB A/S SPONSORED ADR | 3.8% |
|
COGENT BIOSCIENCES INC | 3.5% |
|
NUVALENT, INC. CLASS A | 3.4% |
|
EXELIXIS INC | 3.3% |
|
ABBVIE INC | 2.8% |
CANC Underweight Relative to XPH
|
TARSUS PHARMACEUTICALS, INC. | -3.4% |
 |
JAZZ PHARMACEUTICALS PLC | -3.0% |
|
CRINETICS PHARMACEUTICALS INC | -3.0% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.9% |
|
CORCEPT THERAPEUTICS INC | -2.7% |
|
AXSOME THERAPEUTICS, INC. | -2.7% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.7% |
|
ELANCO ANIMAL HEALTH, INC. | -2.7% |
|
LIGAND PHARMACEUTICALS-CL B | -2.5% |
|
ROYALTY PHARMA PLC CLASS A | -2.5% |